120例乳腺癌组织中HDAC-1蛋白表达的临床病理
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

南通市科技局社会发展计划资助(S2007012)


HDAC-1 protein expression in one hundred and twenty cases of breast cancer
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:探讨乳腺癌组织中组蛋白去乙酰化酶-1(histone deacetylase 1,HDAC-1)的表达意义及其与临床病理特征之间存在的相关性-方法:应用免疫组织化学Envision二步法检测120例乳腺癌组织和对照组20例乳腺增生症乳腺组织中HDAC-1蛋白的表达,分析其与临床特征,以及常规检测指标雌激素受体(ER)-孕激素受体(PR)-人表皮生长因子受体-2(human epidermalgrowth factor receptor-2,HER-2)之间的关系-结果:120例乳腺浸润性导管癌中,HDAC-1高表达43例(35.83%),对照组20例乳腺增生病变中HDAC-1低表达或不表达,两者之间表达差异有统计学意义-乳腺癌中HDAC-1高表达与年龄-临床分期-HER-2表达均有显著相关性(P < 0.01),即与患者年龄 > 50岁组(49.50%)和临床分期为Ⅲ~Ⅳ期组(64.28%)及HER-2(55.26%)的表达呈正相关;与肿瘤的大小-组织学分级-淋巴结转移的有无-以及癌组织间及癌旁组织中有无淋巴细胞的浸润无相关(P > 0.05),与ER(33.89%)-PR(39.28%)的表达无相关(P > 0.05)-结论:HDAC-1在乳腺癌和良性增生性病变诊断及鉴别诊断中有参考意义;HDAC-1蛋白在乳腺癌的发生发展中起重要作用;HDAC-1抑制剂有望成为乳腺癌治疗的新靶向药物-

    Abstract:

    Objective:To investigate the correlation between histone deacetylase 1(HDAC-1) expression and clinical pathological significance. Methods:HDAC-1 protein expression in 120 cases of breast cancers and a control group of 20 cases of breast hyperplasia in breast tissue were examined by immunohistochemical, and the relationships between HDAC-1 protein and clinical features and conventional detection index of ER, PR, HER-2 were analyzed. Results:Among 120 patients with breast cancer, HDAC-1 was high expressed in 43 cases(35.83%), but HDAC-1 was low expressed or not in control group, the difference was significant. HDAC-1 in breast cancers with high expression was significantly correlated with age, clinical stage, HER-2, expression(all P < 0.05): patients who were older than 50 years(49.50%), in clinical period of stage Ⅲ ~ Ⅳ(64.28%), or HER-2(55.26%) was positive correlation with HDAC-1 high expression, but HDAC-1 expression was negatively correlated with tumor size, histological grade, with or without lymph node metastasis, and cancer tissues and adjacent tissues without infiltration of lymphocytes, and ER(33.89%) or PR(39.28%) expression(P > 0.05). Conclusion: HDAC1 protein plays an important role in the development of breast cancer, and HDAC-1 inhibitor is expected to become a new targeting drug for breast cancer treatment.

    参考文献
    相似文献
    引证文献
引用本文

杨书云,朱兴华,陈亚丽,何 松,张建兵.120例乳腺癌组织中HDAC-1蛋白表达的临床病理[J].南京医科大学学报(自然科学版),2011,(6):877-881

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2010-12-16
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期:
  • 出版日期:
通知关闭
郑重声明